| |
| Issue |
Title |
| |
| Vol 29, No 11 (2024) |
Abnormalities of the nocturnal blood pressure profile: significance, diagnostic possibilities, and therapeutic approaches |
Abstract
PDF (Rus)
|
|
Zh. D. Kobalava, E. A. Troitskaya |
| |
| Vol 28, No 4 (2023) |
Diversity of hypertension in obesity |
Abstract
PDF (Rus)
|
|
G. A. Chumakova, T. Yu. Kuznetsova, M. A. Druzhilov |
| |
| Vol 27, No 7 (2022) |
Heart failure and atrial fibrillation: updates and perspectives |
Abstract
PDF (Rus)
|
|
V. N. Larina, I. K. Skiba, A. S. Skiba, V. G. Larin, E. A. Vartanyan |
| |
| Vol 27, No 6 (2022) |
Combined myocardial perfusion scintigraphy and computed tomography: diagnostic and prognostic value in coronary artery disease |
Abstract
PDF (Rus)
|
|
M. O. Gulya, A. V. Mochula, A. N. Maltseva, K. V. Zavadovsky |
| |
| Vol 27, No 5 (2022) |
Optimization of intravascular volume determination in patients with acute decompensated heart failure |
Abstract
PDF (Rus)
|
|
I. V. Zhirov, S. N. Nasonova, A. A. Syrkhaeva, A. E. Lapteva, Yu. F. Osmolovskaya, O. M. Reitblat, Yu. Sh. Prints, M. A. Shariya, S. N. Tereshchenko |
| |
| Vol 27, No 4 (2022) |
Multiagonists of the “incretin axis” as a promising tool for managing cardiometabolic risk in visceral obesity |
Abstract
PDF (Rus)
|
|
M. A. Druzhilov, T. Yu. Kuznetsova, G. A. Chumakova |
| |
| Vol 26, No 4 (2021) |
Role of macrophages in cardiorenal syndrome development in patients with myocardial infarction |
Abstract
PDF (Rus)
|
|
M. A. Kercheva, V. V. Ryabov |
| |
| Vol 25, No 12 (2020) |
Electrocardiographic signs of the left main coronary artery disease in acute coronary syndrome |
Abstract
PDF (Rus)
|
|
E. S. Eniseeva, K. V. Protasov, G. P. Gurtovaya |
| |
| Vol 25, No 2 (2020) |
Acute coronary syndrome: how to reduce the residual inflammatory risk? |
Abstract
PDF (Rus)
|
|
V. I. Shalnev |
| |
| Vol 25, No 3 (2020) |
Psychosomatic relationships in patients with hypertension |
Abstract
PDF (Rus)
|
|
Р. М. Larionov |
| |
| No 6 (2019) |
Epidemiology and comorbidity of arterial hypertension and gallstone disease |
Abstract
PDF (Rus)
|
|
I. N. Grigorieva, Yu. I. Ragino, T. I. Romanova |
| |
| No 1 (2019) |
Stroke prevention for non-valvular atrial fibrillation: how to make the right choice of directly acting oral anticoagulants? |
Abstract
PDF (Rus)
|
|
N. N. Kryukov, E. V. Sayutina, A. M. Osadchuk, M. A. Osadchuk |
| |
| No 4 (2018) |
CATESTATIN AS A NOVEL MARKER OF CARDIOVASCULAR RISK IN SYSTEMIC HYPERTENSION |
Abstract
PDF (Rus)
|
|
E. Yu. Gubareva, N. N. Kryukov, I. V. Gubareva |
| |
| No 3 (2018) |
IVABRADINE OUTSIDE THE CLINICAL GUIDELINES: INTEREST OF A PRACTITIONER |
Abstract
PDF (Rus)
|
|
E. I. Tarlovskaya |
| |
| No 3 (2018) |
INHIBITION OF THE FACTOR XA (WITH RIVAROXABAN) SLOW DOWN PROGRESSION, PREVENTS COMPLICATION AND DECREASE MORTALITY IN CORONARY HEART DISEASE |
Abstract
PDF (Rus)
|
|
V. N. Khirmanov |
| |
| No 2 (2018) |
ATORVASTATIN — 20 YEARS IN THE STRUGGLE FOR LIFE |
Abstract
PDF (Rus)
|
|
N. G. Gogolashvili |
| |
| 1 - 16 of 16 Items |
|
